Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Osteoporosis
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women
Technology appraisal guidance [TA160]
Published:
27 October 2008
Last updated:
07 February 2018
Guidance
Tools and resources
Evidence
History
Do no do examples
Do no do examples for Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women
Title
Year published
Impact Level
No results could be found